Dr. Xinghai Wang joined MicuRx in 2010 and was appointed Chief Technology Officer in 2020. Over the past ten years at MicuRx, Dr. Wang has served as project leader, department director and vice president. As the company’s Chief Technology Officer, Dr. Wang has more than 12 years of experience in the development of anti-infective drugs and is responsible for CMC management and parallel drug development in both US and China. Prior to joining MicuRx, Dr. Wang served as project manager of WuXi AppTec, participated in the design and early development of Elbasvir. Dr. Wang received his Ph.D. in Pharmaceutical Chemistry from Fudan University.